High-Risk Chronic Lymphocytic Leukemia in a Young Adult Treated With Reduced-Dosage, Fixed-Duration Ibrutinib and Venetoclax
Journal of Medical Cases · 2026-04 · 17 (4) · 146-152
DOI: 10.14740/jmc5237 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Medical Cases, 2026-04. Verfasst von Caryn Louise D Gutierrez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Hematology, Philippine General Hospital, Manila, Philippines. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Division of Hematology, Philippine General Hospital, Manila, Philippines.
- Department of Pathology and Laboratory Medicine, Philippine General Hospital, Manila, Philippines.
Zitieren
APA
Gutierrez, C. L. D., Quero-Taggaoa, A. K. H., Uy, T. C. F., & Veloso, J. A. D. (2026). High-Risk Chronic Lymphocytic Leukemia in a Young Adult Treated With Reduced-Dosage, Fixed-Duration Ibrutinib and Venetoclax. Journal of Medical Cases, 17(4), 146-152. https://doi.org/10.14740/jmc5237
Vancouver
Gutierrez CLD, Quero-Taggaoa AKH, Uy TCF, Veloso JAD. High-Risk Chronic Lymphocytic Leukemia in a Young Adult Treated With Reduced-Dosage, Fixed-Duration Ibrutinib and Venetoclax. Journal of Medical Cases. 2026;17(4):146-152. doi:10.14740/jmc5237
BibTeX
@article{Gutierrez2026,
author = {Gutierrez, Caryn Louise D and Quero-Taggaoa, Anne Kristine H and Uy, Timothy Carl F and Veloso, Januario Antonio D},
title = {High-Risk Chronic Lymphocytic Leukemia in a Young Adult Treated With Reduced-Dosage, Fixed-Duration Ibrutinib and Venetoclax},
journal = {Journal of Medical Cases},
year = {2026},
volume = {17},
number = {4},
pages = {146--152},
doi = {10.14740/jmc5237}
}
EUVIMED